Chutes & Ladders: Peacock resigns top post at Adolor

Adolor CEO Bruce Peacock has turned in his resignation, announcing he will leave to become CEO of a chain of low-cost healthcare clinics. He joined the company in 2002. Chairman David Madden will take over as interim CEO while the company searches for a replacement.

- read this AP report for more

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.